Skip to main content

Peer Review reports

From: Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates

Original Submission
5 Jan 2023 Submitted Original manuscript
14 Mar 2023 Reviewed Reviewer Report
26 Jun 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 2
26 Jun 2023 Submitted Manuscript version 2
7 Jul 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 3
7 Jul 2023 Submitted Manuscript version 3
10 Jul 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 4
10 Jul 2023 Submitted Manuscript version 4
11 Jul 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 5
11 Jul 2023 Submitted Manuscript version 5
21 Jul 2023 Reviewed Reviewer Report
24 Jul 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 6
24 Jul 2023 Submitted Manuscript version 6
26 Jul 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 7
26 Jul 2023 Submitted Manuscript version 7
26 Jul 2023 Author responded Author comments - Marjo S. Knaap
Resubmission - Version 8
26 Jul 2023 Submitted Manuscript version 8
Publishing
2 Aug 2023 Editorially accepted
17 Aug 2023 Article published 10.1186/s12883-023-03354-9

You can find further information about peer review here.

Back to article page